DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
LOPINAVIR;RITONAVIR
4
Combination
Approved
Unknown
ORAL
Unknown
Unknown
LOPINAVIR;RITONAVIR
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FILGRASTIM-AAFI
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
FILGRASTIM-AAFI
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PROMESTRIENE
4
Small molecule
Approved
Unknown
Unknown
Hypospadias
Unknown
PROMESTRIENE
×
Maximum Phase:
4
First Approval:
None
UNII:
GXM4PER6WZ
Molecule Type:
Small molecule
Molecular Formula:
C22H32O2
Molecular Weight:
328.5
AlogP:
5.35
PSA:
18.46
HBD:
0.0
HBA:
#RotB:
4.0
Source:
HYOSCYAMINE
4
Small molecule
Approved
Unknown
Unknown
Digestive System Diseases
Unknown
HYOSCYAMINE
×
Maximum Phase:
4
First Approval:
None
UNII:
PX44XO846X
Molecule Type:
Small molecule
Molecular Formula:
C17H23NO3
Molecular Weight:
289.37
AlogP:
1.93
PSA:
49.77
HBD:
1.0
HBA:
#RotB:
4.0
Source:
LIDOFLAZINE
4
Small molecule
Approved
Unknown
Unknown
Cardiovascular Diseases
Unknown
LIDOFLAZINE
×
Maximum Phase:
4
First Approval:
None
UNII:
J4ZHN3HBTE
Molecule Type:
Small molecule
Molecular Formula:
C30H35F2N3O
Molecular Weight:
491.63
AlogP:
5.75
PSA:
35.58
HBD:
1.0
HBA:
#RotB:
9.0
Source:
TACALCITOL
4
Small molecule
Approved
Unknown
Unknown
Psoriasis
Unknown
TACALCITOL
×
Maximum Phase:
4
First Approval:
None
UNII:
C2W72OJ5ZU
Molecule Type:
Small molecule
Molecular Formula:
C27H44O3
Molecular Weight:
416.65
AlogP:
5.56
PSA:
60.69
HBD:
3.0
HBA:
#RotB:
6.0
Source:
TRASTUZUMAB-DKST
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
TRASTUZUMAB-DKST
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
303
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA